The diabetes epidemic in the South Pacific: a pilot study utilising hand grip strength in Tonga by Zioupos, Maria-Eleni et al.
118Copyright © All rights are reserved by M-E Zioupos.
Archives of Diabetes & Obesity
Research ArticleISSN: 2638-5910
The Diabetes Epidemic in the South Pacific: A Pilot Study 
Utilising Hand Grip Strength in Tonga
Maria-Eleni Zioupos1*, Joseph Takai2,3, Mehtab Ahmad4 and Peter Zioupos5
1Russells Hall Hospital, General Surgery, West Midlands Deanery, UK
2Prince Wellington Ngu Hospital, Vavau, Tonga
3Fiji School of Medicine, Fiji National University, Fiji 
4Specialist Registrar General Surgery, West Midlands Deanery, UK
5Cranfield Forensic Institute, Cranfield University, Defence Academy of the UK, Shrivenham, UK
*Corresponding author: M-E Zioupos, Russells Hall Hospital, General Surgery, UK
Received:  February 12, 2019                                                                                                                         Published:  February 19, 2019
Abstract
Background: Hand-grip strength (HGS) has been shown recently to help in predicting disease outcomes and assessing health 
risk, particularly in cardiovascular and metabolic disease. Studies confirming its link to diabetes (T2DM) suggest there is potential 
for its use as simple screening tool. This study examined this possibility in a developing-world population, in a cohort of Tongan diabetics. 
Methods: HGS was measured in a randomly selected cohort of patients, comprising in total 149 patients, of which 91 with and 
58 without T2DM. Other measurements recorded included patient demographics, blood pressure and date of diabetes diagnosis. 
Results: HGS was found to reduce significantly with age in all groups and it also related to BMI in males. Binary logistics 
regression models were produced using ‘HGS,’ ‘Age’ and ‘BMI’ which had a sensitivity of 82-84% (M/F) and specificity of 50-57%. 
Conclusions: This study uses one of the well-known effects and complications of T2DM, affected hand grip strength of sufferers, as a parameter in a ‘tool’ to predict the presence of the disease showing very good sensitivity. Further research is needed into the 
more general utility of the tool, while further work may help identify among the diagnosed those who would benefit from specialist treatment.
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Introduction
Type 2 diabetes mellitus (T2DM) is an important target for 
medical research. Its deadly but silent nature means that by the 
time of diagnosis, 50% of sufferers have already developed serious 
complications. [1] These can be classified as macro or micro vascular 
and affect a vast array of organ systems [2]. The complications are confounded and related to impaired microcirculation, altered blood rheology, neuropathy and its concomitant other conditions [3,4]. Musculoskeletal effects include reduced upper-limb strength and poorer muscle quality, which combined with nerve damage, can 
 
lead to severe disability [5-7] As a result, appropriate screening and 
early and accurate diagnosis of T2DM is extremely important. Hand-grip strength (HGS) testing is being increasingly studied as a potential tool for monitoring and predicting cardiovascular and metabolic disease. [8-16] Given the aforementioned musculoskeletal 
consequences of T2DM, various studies have made observations 
on the relationship between HGS and T2DM [13-15] and it is now broadly accepted that HGS is affected in diabetics when compared 
with the general population [16]. Not only this, but further work 
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demonstrated that HGS is actually negatively correlated with HBA1c 
and with the duration of diabetes. [17-18] The numerous potential reasons for this effect include reduced mitochondria in muscle cells, 
reduced glycogen synthesis and increased inflammatory cytokines at a molecular level, and muscle wasting, stiffer joints, connective tissue damage and neuropathy resulting in reduced mobility [14].
It is hypothesized that monitoring this physiological damage 
trajectory in T2DM might add to our knowledge of the disease 
process and even give rise to opportunity for screening. This is 
because research published in the American Journal of Preventative Medicine in 2015 suggested that, even among healthy weight adults, HGS was reduced both in diagnosed and undiagnosed diabetics and that this was reduced in comparison with normal population. 
[19] Indeed, HGS has been found to be inversely associated with incident type 2 diabetes [20] and 2010 research from the University of Washington suggested having a greater grip strength meant you were less likely to be at risk for developing the disease in the future [21]. Since the publication of these observations, Eckman 
et al. [9] developed and presented a model comprising: ‘HGS,’ 
‘age,’ ‘blood pressure’ and ‘BMI’ as a potentially viable method for 
detecting early T2DM risk, in a Kenyan population. Although the researchers did not show how well this model performs in their patient population, they suggested that a tool based on HGS tool can 
be widely available, inexpensive, easy to use and easy to transport [22].
These advantages make such a tool particularly useful in third 
world countries, or for health systems which lack resources. The 
extent to which their model would work in another population or continent, is questionable, however, given the variance in HGS in different ethnic groups that has been observed as part of the 
HELIUS study in 2015 [23] and its association with body weight 
and age [6]. The Kingdom of Tonga, like many of the Pacific nations, 
is a country experiencing a T2DM epidemic [24], where prevalence 
of the disease has doubled since 1973, but 80% of sufferers 
remain undiagnosed [25]. Primary care is under strain and Tongan 
hospitals (such as the Prince Wellington hospital on Northern island set Vavau used here) are under-resourced for provision of 
effective T2DM prevention, screening and care [26].
 The present study explores the potential for using a simple mechanical device, used to produce HGS values, in medical diagnosis 
and prevention care clinical routines. It employs HGS testing in 
cohort of people that presented themselves to clinics in Tonga 
to screen for those among them at high risk of T2DM. The study aims to combine HGS to some other basic patient metrics similarly to some very recent previous studies [9, 13-16], but now applied for a completely different and challenging demographic cohort of 
a south east Asian population. The topic concerns one of the most important public health challenges in modern medicine and relates musculoskeletal complications with metabolic medicine. Greater accuracy in knowledge of diabetic complications and their effects on 
the body, could mean more accurate diagnosis and management of 
a silent and destructive disease. Recent studies confirm, hand-grip strength testing has ever-widening prospects for its application to 
various medical fields. Moreover, the work offers an opportunity to 
gather original data on a little-studied population so as to explore 
the utilization of such a tool in an under-resourced developing world diabetes epidemic. 
Patients and Methods
The research was performed in the outpatient clinics of Prince 
Wellington NGU District Hospital, Neiafu, Vavau, in the Kingdom 
of Tonga in the South Pacific. A total of 149 participants were 
recruited at the outpatient clinic at Prince Wellington hospital and 
at one outreach clinic, set up at a nearby island location. Patients 
were opportunistically selected after being identified on the basis 
of a T2DM diagnosis, or the absence of a diagnosis of T2DM over 
the course of 1 month of clinics. The clinic for diabetes took place twice a week, hypertension clinic once a week and all other clinics 
examined mixed cases. Participants included were consenting 
Tongans with diagnosis of T2DM, or not diagnosed with diabetes 
(NDD). Participants excluded were those completely unable to 
perform grip dynamometry because of hand/upper-limb loss. A 
total of 4 acutely unwell patients were excluded from the research on their being admitted to the hospital. All participants were consented by means of a written consent form outlining that other 
than hand-grip strength; they would receive no immediate result following the assessment.Consent was obtained following reading an information sheet. 
Health care professionals gave an explanation of the research to the group as a whole prior to every clinic, when the patients gathered 
in the waiting room. Patients were explained the research in their clinic appointment by means of a translated information sheet and gave written consent via consent form. Each patient was allocated 
a non-identifiable code. Data was electronically recorded under that code. Consent forms were signed and kept by the researcher. Measurements to be taken were to be determined by the availability 
of hospital time and resources. In order to produce a model 
comparable to [9] at least Age, BMI, BP and HGS measurements would have to be recorded. Ultimately patient measurements of 
Age, Sex (M/F), Comorbidities, Medications, Smoking habit (Y/N) 
were collected by the doctor seeing the patient in clinic. Diabetics were also asked the additional questions as to whether they had 
a Diagnosis of T2DM (Y/N), Date of diagnosis, Family history of 
diabetes (if known). BP, Height, Weight and therefore (BMI) were measurements obtained by the hospital nurses prior to the patients’ clinic appointments.
Handedness (R/L/U) and 3 test values on grip strength were measured by one and the same researcher. Hand-grip strength 
measurements were taken to be the maximum force measured 
by a Takei digital grip-strength dynamometer (TKK5401 Grip-D, 
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Takei Sci. Instr. Co. Ltd. Niigata, JP) in a ‘best-of-three’ test. Testing 
was standardized by determining patient dominance of hand and ensuring a standing, or seated posture with the tested arm hanging. 
Three measurements were recorded per hand each preceded by a 30s pause for rest in-between. All participants received a full 
demonstration with the hand dynamometer prior to testing. Data and statistical analysis were performed in the UK with use of the 
computer package Minitab® version 17.3.1 and with the help of 
Cranfield University statisticians.
Results
Patient Sample Demographics
Data was collected on a total of 149 patients, including 91 
patients with a diagnosis of T2DM and 58 without a diagnosis of 
T2DM. The sample size was determined by the time and resources available and was planned to be comparable to other such bespoke studies globally. Anthropometric values and the matching between 
groups are shown in Table 1. 
Table 1: Patient demographics for age, height, weight, BMI, systolic and diastolic blood pressure, duration of disease and HGS.
Variable Sex (M/F) Total Count Mean St Dev Total Count Mean St Dev *P (<0.05)
Age (Y)
F 42 58.45 12.92 54 57.41 10.88 0.668M 16 63.81 13.29 37 57.05 9.03 0.036*Height (m) F 42 1.6325 0.0605 54 1.6486 0.0498 0.168M 16 1.7036 0.0704 37 1.7644 0.0563 0.002*Weight (kg) F 42 99.85 22.16 54 91.63 14.49 0.031*M 16 89.22 17.66 37 101.57 16.53 0.018*
BMI (kg/m2) F 42 37.43 8.11 54 33.598 5.03 0.005*M 16 30.56 4.78 37 33.504 5.619 0.074
Systolic BP
F 42 134.43 18.87 54 138.04 17.76 0.339M 16 134.81 26.74 37 140.68 18.58 0.362
Diastolic BP
F 42 75.55 14.67 54 78.09 13.47 0.379M 16 73.5 16.45 37 77.3 10.91 0.326
Duration (Y)
F 42 - - 54 7.585 5.51 N/AM 16 - - 37 7.11 7.73 N/AHGS (kgf) F 42 27.67 7.11 54 26.34 7.3 0.373^M 16 38.94 9.13 37 42.37 11.96 0.311^
*indicates statistically significant difference between control and diabetic population.
^ HGS was not found to be significantly different between controls and diabetics in this population. 
Duration (Y) since diagnosis for T2DM patients only.
Relationship Between HGS and Other Patient VariablesMuscle performance and strength has been linked to body weight and age in the absence and presence of T2DM [6]. We looked for the presence of a pattern separately for males and females 
(Table 2).
Table 2: Correlations between: Age, systolic BP, diastolic BP, BMI, HGS in Males.
Age Systolic BP Diastolic BP BMI
Systolic BP
0.2940.033*
diastolic BP
-0.135 0.5340.335 0.000*
BMI
-0.301 0.029 0.1320.029* 0.835 0.348
HGS -0.636 -0.177 0.098 0.3570.000* 0.204 0.484 0.009*
Cell Contents: top value is the Pearson correlation; Underneath is the P-Value where *indicates statistical significant correlation 
between these variables.
The last row in Table 2 shows that HGS correlates significantly 
with Age and BMI, as shown in Figure 1 below (Diabetics in red; 
Controls in blue). Systolic BP, BMI and HGS also showed a significant 
effect with Age. HGS rose faster as function of BMI and declined 
slower as a function of Age in controls (Table 3) (Figure 1).
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                                                       (a)                                                                                                               (b)
Figure 1: (a) HGS vs. Age in Males; (b) HGS vs. BMI in Males. (Controls – blue symbols; T2DM – red symbols).
Table 3: Correlations between: Age, systolic BP, diastolic BP, BMI, HGS in Females.
Age    Systolic BP  Diastolic BP BMI
Systolic BP       0.116    0.262    
diastolic BP            -0.161 0.605   0.118  0.000*   
BMI                             -0.211 0.22 0.178   0.039*  0.031* 0.083HGS                -0.648 -0.141 0.126 0.174 0.000*  0.172 0.223 0.091
Cell Contents: top value is the Pearson correlation; Underneath is the P-Value where *indicates statistical significant correlation 
between these variables.
In Table 3, HGS is shown to correlate significantly with Age 
and no other variable. This is shown in Figure 2. There were cross 
correlations of BMI with Age and systolic BP. The rate of change 
of HGS with Age and of HGS vs. BMI was identical in diabetics and 
controls (Diabetics in red; Controls in blue) (Figure 2).
                                                       (a)                                                                                                               (b)
Figure 2: (a) HGS vs. Age in Females; (b) HGS vs. BMI in Females. (Controls – blue symbols; T2DM – red symbols).
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Effects on ‘HGS’ of: Age – Systolic Bp – Diastolic Bp – BMI 
- ‘Duration Of Disease’ Within The Diseased Population 
for Males and Females
Duration is the only other factor not considered thus far as it 
applies only to the diseased group. This was explored via a multi-
factorial regression relationship using the ‘stepwise regression’ routine in Minitab®. All available variables were considered by 
the programme and the level to enter or exit the regression was a=0.15. Eventually only those variables, which have a statistically 
significant effect on HGS were retained within this generalized 
linear model (Table 4).
Table 4: Stepwise regression output for Males.
Analysis of Variance for MALES
Source DF Adj SS Adj MS F-Value P-ValueRegression 1 1915 1914.59 25.7 0.000*Age 1 1915 1914.59 25.7 0.000*Error 33 2458 74.49
Total 34 4373S R-sq R-sq(adj) R-sq(pred)
8.63077 43.78% 42.08% 36.68%
Equation 1 = HGS = 92.90 - 0.881 Age (62.06kgf for a 35yr old male adult).
HGS correlated with both Age and BMI in males (Table 2), but in the generalised linear model the cross correlation between Age and 
BMI was such that only one of them stayed as the more dominant one, Age (Table 5).
Table 5: Stepwise regression output for Females.
Analysis of Variance for FEMALES
Source DF Adj SS Adj MS F-Value P-ValueRegression 1 2117 2116.92 69.83 0.000*Age 1 2117 2116.92 69.83 0.000*Error 93 2819 30.32
Total 94 4936S R-sq R-sq(adj) R-sq(pred)5.50599 42.88% 42.27% 40.23%
Equation 2 = HGS = 50.36 - 0.4039 Age (36.22kgf for a 35yr old female adult). 
In both males and females, the regression shows that still only ‘Age’ can be used to predict ‘HGS’ in the sufferers, even when ‘duration’ is considered. Unlike other studies the ‘duration’ is not a 
significant reliable factor. However, ‘duration’ is essentially the time 
since diagnosis, and this then may reflect in fact the performance of the local health care system in diagnosing sufferers late or reporting them accurately.
Binary Logistics Regressions: A Model to Predict Likelihood of Suffering with T2DM based on ‘HGS’, ‘BMI’ and ‘Age’ 
values
Table 6: Males as a function of HGS, BMI, Age.
Deviance Table
Source              DF Adj Dev Adj Mean  Chi-Square P-Value  Regression            3 6.7994 2.2665 6.8 0.079 (NS at P=0.05)  HGS                  1 0.5387 0.5387 0.54 0.463   (Not significant)
  BMI                1 1.9088 1.9088 1.91 0.167 (Not significant)  Age              1 2.9858 2.9858 2.99 0.084  (Not significant)Error  49 58.1208 1.1861    
Total    52 64.9202     
Goodness-of-Fit Tests
Test               DF Chi-Square  P-Value    
Deviance              49 58.12 0.175    
Pearson           49 57.47 0.19    Hosmer-Lemeshow 8 5.01 0.757    
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A predictive model can be produced by using binary logistics regression where the output is not a continuous variable but in 
binary form (0 for controls and 1 for diabetics) (Table 6).
Model-1: Binary Logistics Regression Equation for Males
( ) ( ) ( )( ) 1   ' /  1  'P exp Y exp Y= +  (Probability of having the 
disease)
Equation 3:
'  2.98  0.0272   0.0959   0.0681 Y HGS BMI Age= − + −  (Figure 3) 
(Table 6)
Diagnostic Test Evaluation: For the purposes of screening and to demonstrate the performance of the model, at an arbitrary probability threshold of 0.6, the model would have correctly 
identified 31 as true positive (TP), misdiagnosed 6 as false negative 
(FN), and also given for the controls a random 50/50 split, that is 8 
true negative (TN) and 8 false positive (FP).As a result
a. Sensitivity = 84% [95%CI=68-94%]
b. Specificity = 50% [95%CI=25-75%]
c. Disease prevalence = 70% [95%CI=56-82%]
d. Positive predictive value= 80% [95%CI=70-87%]
e. Negative predictive value = 57% [95%CI=36-76%].
                                                       (a)                                                                                                               (b)
Figure 3: (a) Individual probability of disease values in the whole Male cohort against true disease status (0 – normal, 1- 
diseased)  (b) Cumulative probability function for the same.  Based on the above model, normals were given on average lower 
probability values than the diseased cohort.  This was statistically significant as shown by a T-test, P value = 0.005, with a 95% 
Confidence interval for the mean for Normals [0.53-0.68] and Diabetics [0.69-0.79].
Table 7: For Females as a function of HGS, BMI, Age.
Deviance Table
Source         DF  Adj Dev   Adj Mean Chi-Square  P-Value  Regression             3 11.118 3.706 11.12 0.011  (* at P=0.05)  HGS             1 2.12 2.12 2.12 0.145   (Not significant)
  BMI               1 8.478 8.478 8.48 0.004  (* at P=0.05)  Age                    1 3.065 3.065 3.06 0.08  (Not significant)Error        92 120.462 1.309    
Total    95 131.58     
Goodness-of-Fit Tests
Test            DF    Chi-Square P-Value 
Deviance    92 120.46 0.025 
Pearson              92 99.78 0.272 Hosmer-Lemeshow 8 13.41 0.098 
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Model- 2: Binary Logistics Regression Equation for Females ( ) ( ) ( )( ) 1   ' /  1  'P exp Y exp Y= +  (Probability of having the disease)
Equation 4:
'  7.73  0.0578   0.0968   0.0429 Y HGS BMI Age= − − −  (Figure 4) (Table 7)
                                                       (a)                                                                                                               (b)
Figure 4: (a) Individual probability of disease values in the whole Female cohort against true disease status (0 – normal, 1- 
diseased)  (b) Cumulative probability function for the same.  Based on the above model, normals were given on average lower 
probability values than the diseased cohort. This was statistically significant as shown by a T-test, P value < 0.000, with a 95% 
Confidence interval for the mean for normals [0.45-0.54] and Diabetics [0.57-0.66].
Binary Logistics Regression: A Model for Predicting Likelihood of Suffering with T2DM based on ‘HGS’, ‘BMI’, ‘Age’, 
‘Systolic’ and ‘Diastolic’ Blood Pressure Values (Table 8)
Table 8: For Males as a function of HGS, BMI, Age and the systolic and diastolic blood pressure values.
Deviance Table
Source           DF Adj Dev  Adj Mean  Chi-Square  P-Value  Regression       5 9.0486 1.8097 9.05 0.107  (NS at P=0.05)  HGS                   1 0.5129 0.5129 0.51 0.474  
  BMI            1 1.1456 1.1456 1.15 0.284    Age        1 4.369 4.369 4.37 0.037    (* at P=0.05)
  systolicBP          1 1.8883 1.8883 1.89 0.169  
  diastolicBP         1 0.1339 0.1339 0.13 0.714  Error          47 55.8716 1.1888    
Total    52 64.9202     
Goodness-of-Fit Tests
Test             DF   Chi-Square  P-Value    
Deviance      47 55.87 0.176    
Pearson  47 60.12 0.095    Hosmer-Lemeshow 8 10.09 0.259    
Diagnostic Test evaluation: For the purposes of screening and to demonstrate the performance of the model, at an arbitrary probability threshold of 0.5, the model would have correctly 
identified 44 (TP), misdiagnosed 10 (FN), and also given us for the 
controls 24 (TN) and 18 (FP).
As a result:
a. Sensitivity = 82% [95%CI=69-91%]
b. Specificity = 57% [95%CI=41-72%]
c. Disease prevalence = 56% [95%CI=46-66%]
d. Positive predictive value= 71% [95%CI=63-78%]
e. Negative predictive value = 71% [95%CI=56-82%]
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Model-3: Binary Logistics Regression Equation for Males
( ) ( ) ( )( ) 1   ' /  1  'P exp Y exp Y= +
 Equation 5:
'   2.30  0.0271   0.0708   0.0932   0.0284    0.0123  Y HGS BMI Age systolic BP diastolic BP= − + − + −
(Figure 5) (Table 8)
                                                       (a)                                                                                                               (b)
Figure 5: (a) Individual probability of disease values in the whole Female cohort against true disease status (0 – normal, 1- 
diseased)  (b) Cumulative probability function for the same.  Statistically different behaviours, ANOVA: P value = 0.001, 95% 
Confidence interval for the mean = Normals [0.49-0.66], Diabetics [0.70-0.81] .
For a cut off probability value of 0.6 / the performance was: 78% (TP), 22% (FN), 44% (TN), 56%(FP). 
Model-4: Binary Logistics Regression Equation for Females
( ) ( ) ( )( ) 1   ' /  1  'P exp Y exp Y= +
Equation 6:
'   5.29  0.0560   0.1157   0.0476   0.0203    0.0076  Y HGS BMI Age systolic BP diastolic BP= − − − + +
 (Figure 6) (Table 9).
                                                       (a)                                                                                                               (b)
Figure 6: (a) Individual probability of disease values in the whole Female cohort against true disease status (0 – normal, 1- 
diseased)  (b) Cumulative probability function for the same.  Statistically different behaviours, ANOVA: P value < 0.000, 95% 
Confidence interval for the mean = Normals [0.42-0.53], Diabetics [0.58-0.67].
For a cut off probability value of 0.48 / the performance was: 82% (TP), 18% (FN), 57% (TN), 43%(FP). 
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Table 9: For Females as a function of HGS, BMI, Age and the systolic and diastolic blood pressure values.
Deviance Table
Source       DF Adj Dev Adj Mean  Chi-Square P-Value  Regression        5 14.526 2.9052 14.53 0.013  (* at P=0.05)  HGS            1 1.869 1.8693 1.87 0.172  
  BMI             1 10.881 10.8815 10.88 0.001   (* at P=0.05)  Age              1 3.439 3.4393 3.44 0.064  (* at P=0.10)
  systolicBP          1 1.483 1.4834 1.48 0.223  
  diastolicBP     1 0.131 0.1314 0.13 0.717  Error         90 117.054 1.3006    
Total         95 131.58     
Goodness-of-Fit Tests
Test        DF       Chi-Square  P-Value
Deviance        90 117.05 0.029
Pearson        90 99.19 0.238Hosmer-Lemeshow 8 5.32 0.722
Discussion 
The aim of this study, which was carried on diabetic patients 
in a third world country, was to examine whether, after collecting a set number of physiological measurements including HGS, it is possible to ascertain the likelihood of being at high risk of suffering 
with T2DM. This is against a background of research suggesting that HGS, a musculoskeletal measurement which is affected in 
T2DM, appears to carry additional diagnostic value for screening in musculoskeletal and neuronal diseases. 
The method was taken to the Kingdom of Tonga where it would be challenged because of the very different ethnic, continental and lifestyle background. Consequently, the results of this work do not mirror results demonstrated in some other previous studies as in 
this patient sample we found no statistically significant difference 
in HGS between controls and diabetics (Table 1). As shown in 
Relationship Between HGS and Other Patient Variables’ HGS relates 
to Age and BMI; high BMI for high HGS and thus increased BMI 
which also would be a factor for T2DM was already linked to HGS 
skewing the data. HGS, on the whole, correlated significantly with age in both men and women in this population and this is regardless 
of diabetic status (Figure 1a & 2a). This relationship was stronger 
in diabetics, both male and female. The relationship between HGS 
and BMI was statistically significant in males but not in females 
(Figure 1b & 2b). As shown in section where the relationship between HGS and 
‘duration’ of disease is examined and in conjunction with other 
variables, this was not significant. That may have been due to a 
limitation in accuracy of defining ‘duration’. It is not possible to 
be confident that the duration of the disease which was assessed from the date they were diagnosed locally was accurate because the locals, compared to other populations, do not attend hospitals, they do not have any primary care physicians to be seen to, knowledge about diabetes and its impact is very poor and the urgency to deal 
with a suspected condition is lacking. This is further compounded by the possibility that even within the ‘controls’ there may have 
been sufferers who were undiagnosed T2DM. 
The best results were produced by use of the binary logistics 
models -1 to -4. These were able to apportion probability values 
above 0.5 (>50% chance of having T2DM) to the vast majority of the sufferers, while apportioning random values of diabetes likelihood to the controls (probability values spreading across the whole 
range from 0 (0%) to 1 (100%)). As a result, on ‘evaluation of the models as a diagnostic test’ model -1 and -2 for instance for a cut-
off value of probability of 50% it would have given true positive 
(TP) for 82-84% of diabetics (good sensitivity) but would also have 
false positively (FP) identified 50-57% of the controls (lacking in 
specificity) in males (model-1) and females (model-2) respectively. 
The model input and output variables were similar to those used in a previous study that of Eckman et al. [9]. However, it is not clear if the model in the Eckman et al. study performed well because 
the authors did not show proof of fit, or performed the statistics 
tests shown here. They also did not show specificity and sensitivity values (diagnostic test evaluation).
 The present study performed less well than other research 
probably because of the different context and/or various limitations, particularly the choice and characteristics of the 
patient sample. HGS has been shown to depend on BMI and the 
Tongans show by global standards uncharacteristically high BMI 
values for both males and females. Perhaps, as shown in Table 1, 
the difference in variations such as gender, age and BMI between the cohorts meant that the populations were not ideally matched. 
There is an extremely high prevalence of diabetes in Tonga and 
so finding patients without a diagnosis of diabetes is a challenge. 
In addition, the recruited ‘control’ volunteers were from other outpatient clinics and therefore, it cannot be dismissed that they were suffering from other conditions, such as obesity, hypertension 
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or dyslipidemia, which may have equally well affected the 
physiological measurements values and HGS. Notably, the average 
BMI of the female control group was higher than that of the female 
diabetic group (see Table 1) and the opposite was true for the 
males; and in both sexes HGS followed the same patterns as BMI. 
It should also be noted that four acute cases were not included in 
T2DM because they were managed on an urgency basis and thus were not part of the study which searches for a diagnostic method 
for T2DM. 
The HGS values produced may be affected by some other 
musculoskeletal dysfunctions and are not diabetes specific. It is also possible, for instance, that patients may have been suffering from undiagnosed conditions, e.g. arthritis, which made use of the 
dynamometer difficult. There is also no standardized method for 
choice of size of hand-grip dynamometer because there are no 
known guidelines. It would be good to produce such rules in a future study. HGS data collection and performance was not blinded and was visible to the researcher and the participant so as to encourage 
maximum grip strength. There were sex differences, women tended to approach the dynamometer with some timidity, and it may be 
the case that culturally the Tongan women find it difficult to exert themselves in public. 
 The choice of variables used in this study was limited by the resources on offer locally. HbA1c recording might have been useful, but not all patients had these available. HbA1c measurements would apportion an objective severity of diabetes score rather than depend on the qualitative status allocated by local doctors. Smoking is another variable which is known to have an effect on 
hand-grip strength. Our data obtained on smoking (including date stopped, number a week prior to stopping etc.) was of limited use 
and could have been more accurately obtained. Because of cultural pressure the answer to this question may have been inaccurate 
since patients may have not reported to the doctor truthfully. The outcome to the question of previous family history of diabetes was similarly troublesome as many of the locals could not recall or did not know for certain. 
Conclusion
In the present study we have used a simple mechanical device, used to produce HGS measurements, to ascertain its utility value in medical diagnosis and prevention care clinical routines. We have 
exploited the very presence and occurrence of a musculoskeletal and neuronal complication brought about by the presence of type 2 
Diabetes, in a statistics tool, to predict the presence of the disease 
itself. We have gathered physiological variables such as BMI, BP, Age 
and HGS in a cohort of T2DM sufferers and for a sex/aged matched 
control of non-diabetics to explore the hypothesis that HGS can contribute towards a model for screening and predicting for this 
condition. The significance of the present methodology is that it is the second study of its kind to be performed in a third world setting.
The means and methodology are quite simple and HGS may be a useful measure within a predictive tool by which health risk may 
be assessed in a developing country such as Tonga though more 
research is needed. The use of HGS in combination with Age and 
BMI led to a binary logistic model which apportioned a probability 
of having T2DM more than 0.5 (>50%) for the majority of sufferers and can be used to at least highlight those who should be referred 
for further investigation. The overall impressions for use of the dynamometer were positive in general due to its novelty and men 
in particular enjoy taking part. The HGS tool offers an easy health test which could be used by non-medically trained professionals in 
order to screen a population such as that in Tonga where doctors are rare and there is much reliance on aid from other countries. 
Tongan health care struggles with the burden of screening for 
T2DM, in which case monitoring and treating diabetes, through perhaps early diagnosis and prevention, may in fact be the best cure 
in this context.
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